1.
Hepatitis B virus infection in Belgium: preliminary results of the Belgian Association for the Study of the Liver (BASL) registry of HBsAg chronic carriers
2.
3.
4.
5.
6.
7.
Ethnic epidemiological profiles and antiviral therapy among patients infected with hepatitis C virus genotype 4: a multicenter study from Belgium.
Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium
Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium
The prognosis of hepatitis Delta infections in Belgium is poor and determined by the hepatitis Delta viremia.
Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium
Hepatitis B virus and hepatitis C virus infection in Belgium: similarities and differences in epidemic and initial management